skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Index

A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people

Kim, Hye-Jin ; Hwang, Seoyeon ; Lee, Somin ; Kwon, Yunhyung ; Park, Kwangsook ; Park, Young Joon ; Bae, Geun-Ryang ; Lee, Sang Won ; Jeong, Yong-Seok ; Hyeon, Ji-Yeon

BMC infectious diseases, 28 March 2015, Vol.15, pp.164 [Peer Reviewed Journal]

Full text available

View all versions
Citations Cited by
  • Title:
    A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people
  • Author: Kim, Hye-Jin ; Hwang, Seoyeon ; Lee, Somin ; Kwon, Yunhyung ; Park, Kwangsook ; Park, Young Joon ; Bae, Geun-Ryang ; Lee, Sang Won ; Jeong, Yong-Seok ; Hyeon, Ji-Yeon
  • Description: A worldwide poliomyelitis eradication program was initiated in 1988; however, strains of wild poliovirus (WPV) are still endemic in some countries. Until WPV transmission is eradicated globally, importation and outbreaks of WPV are alarming possibilities. This study is the first report to document the polio immunity after 2004, when an inactivated polio vaccine (IPV) was introduced in the Republic of Korea. A total of 745 serum samples from randomly selected patients ranging from 6 to 84 years of age were used for neutralization tests, performed in the World Health Organization polio national reference laboratory. Among the 745 tested sera, 439 (58.9%) were seropositive and 19 (2.6%) were seronegative to all PV serotypes. In all age groups, PV3 showed the lowest level of seroprevalence, at 509 cases (68.3%), compared to 616 (82.7%) for PV1 and 685 (91.9%) for PV2. In the 6-10-year age group, which included IPV-immunized children, the highest seropositive rate was observed and the difference in seroprevalence between PV3 and other serotypes was the lowest compared to the other age groups immunized with oral PV vaccines (OPV). In addition, the seronegative rates of all three PV types in children aged 6-10 in this study were found to be lower than those in OPV-immunized children reported in a previous study from the Republic of Korea. Meanwhile, middle-aged subjects (41-60 years) had the lowest seroprevalence and geometric mean titer. This study indicates a deficiency in immunity to PV in middle-aged individuals, and low seroprevalence to PV3 in all age groups. In addition, due to the ongoing risk of importing PV, middle-aged people should consider PV vaccination before visiting a PV-endemic country. Our findings provide data to assist those involved in deciding future national polio vaccination strategies for the maintenance of a polio-free status in Korea.
  • Is Part Of: BMC infectious diseases, 28 March 2015, Vol.15, pp.164
  • Identifier: E-ISSN: 1471-2334 ; PMID: 25881203 Version:1 ; DOI: 10.1186/s12879-015-0894-z
  • Subjects: Antibodies, Viral -- Immunology ; Disease Outbreaks -- Prevention & Control ; Poliomyelitis -- Prevention & Control ; Poliovirus -- Immunology ; Poliovirus Vaccine, Inactivated -- Immunology
  • Language: English
  • Source: MEDLINE/PubMed (U.S. National Library of Medicine)

Searching Remote Databases, Please Wait